CA2030178A1 - Transdermal therapeutic system comprising as active component buprenorphine - Google Patents
Transdermal therapeutic system comprising as active component buprenorphineInfo
- Publication number
- CA2030178A1 CA2030178A1 CA2030178A CA2030178A CA2030178A1 CA 2030178 A1 CA2030178 A1 CA 2030178A1 CA 2030178 A CA2030178 A CA 2030178A CA 2030178 A CA2030178 A CA 2030178A CA 2030178 A1 CA2030178 A1 CA 2030178A1
- Authority
- CA
- Canada
- Prior art keywords
- buprenorphine
- transdermal therapeutic
- therapeutic system
- active component
- active substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RMRJXGBAOAMLHD-IHFGGWKQSA-N buprenorphine Chemical compound C([C@]12[C@H]3OC=4C(O)=CC=C(C2=4)C[C@@H]2[C@]11CC[C@]3([C@H](C1)[C@](C)(O)C(C)(C)C)OC)CN2CC1CC1 RMRJXGBAOAMLHD-IHFGGWKQSA-N 0.000 title abstract 3
- 229960001736 buprenorphine Drugs 0.000 title abstract 3
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 239000010410 layer Substances 0.000 abstract 3
- 239000013543 active substance Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 239000004820 Pressure-sensitive adhesive Substances 0.000 abstract 1
- 238000013270 controlled release Methods 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 239000011241 protective layer Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Laminated Bodies (AREA)
Abstract
The controlled release of buprenorphine or the pharma-ceutically acceptable salts thereof to the skin over a period of time of at least 24 hours is ensured by a transdermal therapeutic system consisting of a backing layer which is impermeable to the active substance, a pressure-sensitive adhesive reservoir layer, and op-tionally a removable protective layer. Said reservoir layer of said system comprises 20 to 90%-wt polymeric material, 0.1 to 30%-wt softener, 0.1 to 20%-wt bupre-norphine base or one of the pharmaceutically accepta-ble salts thereof, and 0.1 to 30%-wt solvent for the active substance base.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3939376A DE3939376C1 (en) | 1989-11-29 | 1989-11-29 | |
| DEP3939376.3-41 | 1989-11-29 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2030178A1 true CA2030178A1 (en) | 1991-05-30 |
| CA2030178C CA2030178C (en) | 1995-08-15 |
Family
ID=6394373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002030178A Expired - Lifetime CA2030178C (en) | 1989-11-29 | 1990-11-16 | Transdermal therapeutic system comprising as active component buprenorphine |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP0430019B1 (en) |
| JP (1) | JPH0818984B2 (en) |
| KR (1) | KR950015061B1 (en) |
| AT (1) | ATE135205T1 (en) |
| AU (1) | AU632182B2 (en) |
| CA (1) | CA2030178C (en) |
| CZ (1) | CZ282557B6 (en) |
| DE (2) | DE3939376C1 (en) |
| DK (1) | DK0430019T3 (en) |
| ES (1) | ES2086353T3 (en) |
| FI (1) | FI100379B (en) |
| GR (1) | GR3020177T3 (en) |
| HR (1) | HRP930675B1 (en) |
| HU (1) | HU206266B (en) |
| IE (1) | IE73247B1 (en) |
| IL (1) | IL96243A (en) |
| MY (1) | MY105347A (en) |
| NO (1) | NO303107B1 (en) |
| NZ (1) | NZ236191A (en) |
| PL (1) | PL165396B1 (en) |
| PT (1) | PT96028B (en) |
| SI (1) | SI9012260B (en) |
| SK (1) | SK279687B6 (en) |
| YU (1) | YU47956B (en) |
| ZA (1) | ZA909544B (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6868286B1 (en) | 1998-11-03 | 2005-03-15 | Lts Lohmann Therapie-Systeme Ag | Device for a transdermal and phonophoretic combination therapy and the use thereof in a method for medical application |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5069909A (en) * | 1990-06-20 | 1991-12-03 | Cygnus Therapeutic Systems | Transdermal administration of buprenorphine |
| US5762952A (en) * | 1993-04-27 | 1998-06-09 | Hercon Laboratories Corporation | Transdermal delivery of active drugs |
| DE4446600A1 (en) * | 1994-12-24 | 1996-06-27 | Lohmann Therapie Syst Lts | Transdermal absorption of active ingredients from supercooled melts |
| US6344211B1 (en) | 1994-12-24 | 2002-02-05 | Lts Lohmann Therapie-Systeme Gmbh | Transdermal absorption of active substances from subcooled melts |
| JPH1036265A (en) * | 1996-07-19 | 1998-02-10 | Nitto Denko Corp | Buprenorphine transdermal preparation |
| DE19705138A1 (en) * | 1997-02-11 | 1998-08-13 | Lohmann Therapie Syst Lts | Stretchy transdermal therapeutic system |
| US5968547A (en) | 1997-02-24 | 1999-10-19 | Euro-Celtique, S.A. | Method of providing sustained analgesia with buprenorphine |
| DE19738855C2 (en) | 1997-09-05 | 2001-01-04 | Lohmann Therapie Syst Lts | Transdermal therapeutic system with adhesive reservoir layer and unidirectional elastic back layer |
| DE19828273B4 (en) * | 1998-06-25 | 2005-02-24 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system containing hormones and crystallization inhibitors |
| DE19901085C2 (en) * | 1999-01-14 | 2003-12-18 | Lohmann Therapie Syst Lts | Transdermal therapeutic system with a self-adhesive matrix containing organic acid addition salts of morphine or morphine type alkaloids |
| DE19923551A1 (en) * | 1999-05-21 | 2000-11-30 | Lohmann Therapie Syst Lts | Pharmaceutical preparation with the active ingredient diamorphine and its use in a method for treating opiate addiction |
| DE10056014A1 (en) * | 2000-11-11 | 2002-05-16 | Beiersdorf Ag | Laminated plaster with active substance, used as transdermal therapeutic system, has impermeable barrier layer on side away from skin and separable carrier layer with adhesive on side towards skin |
| DE10056012A1 (en) * | 2000-11-11 | 2002-05-16 | Beiersdorf Ag | Carrier material for medical applications, preferably for transdermal therapeutic system, has aluminum film between carrier and self-adhesive coating |
| JP4194277B2 (en) | 2002-01-25 | 2008-12-10 | 久光製薬株式会社 | Method for producing pressure-sensitive adhesive molded body mainly composed of crosslinked polymer |
| PT1526848E (en) * | 2002-08-09 | 2007-08-08 | Gruenenthal Gmbh | Opioid-receptor antagonists in transdermal systems having buprenorphine |
| DE10237057A1 (en) * | 2002-08-09 | 2004-03-25 | Grünenthal GmbH | Transdermal therapeutic systems containing buprenorphine, useful in treating pain or urinary incontinence, also containing mu-, kappa- or delta-opioid receptor antagonist to reduce abuse potential |
| PL1610791T3 (en) | 2003-03-31 | 2011-07-29 | Titan Pharmaceuticals Inc | Implantable polymeric device for sustained release of dopamine agonist |
| MXPA06000991A (en) | 2003-07-25 | 2006-04-11 | Euro Celtique Sa | Treatment of dependence withdrawal. |
| DE102004009903A1 (en) | 2004-02-26 | 2005-09-22 | Grünenthal GmbH | Patch with reduced skin irritation |
| EP1743638A1 (en) | 2005-07-15 | 2007-01-17 | Laboratorios Del Dr. Esteve, S.A. | Pharmaceutical formulations of substituted pyrazoline compounds |
| DE102006057083A1 (en) | 2005-12-05 | 2007-06-28 | Lg Electronics Inc. | Lighting device for a refrigerator |
| DE102006054731B4 (en) | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system for administration of the active ingredient buprenorphine and use thereof in pain therapy |
| ES2528650T3 (en) | 2010-11-17 | 2015-02-11 | Hexal Ag | Transdermal therapeutic system comprising buprenorphine |
| DE102011076653A1 (en) | 2011-05-27 | 2012-11-29 | Acino Ag | Transdermal therapeutic system containing buprenorphine and an alpha hydroxy acid |
| TW201338813A (en) | 2011-12-12 | 2013-10-01 | Lohmann Therapie Syst Lts | Transdermal delivery system |
| DE102012000369A1 (en) | 2012-01-11 | 2013-07-11 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermal therapeutic system with cholinesterase inhibitor |
| SG11201509218SA (en) | 2013-06-04 | 2015-12-30 | Lohmann Therapie Syst Lts | Transdermal delivery system |
| DE102014013448A1 (en) * | 2014-09-16 | 2016-03-17 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermal therapeutic system comprising buprenorphine |
| US9656441B2 (en) | 2015-01-08 | 2017-05-23 | Alfred E. Tiefenbacher ( Gmbh & Co. Kg) | Transdermal patch |
| EP3067050A1 (en) | 2015-03-13 | 2016-09-14 | Acino AG | Transdermal therapeutic system with an overtape comprising two adhesive layers |
| CN109045341A (en) * | 2018-05-07 | 2018-12-21 | 武汉兴嘉业堂医疗科技发展有限公司 | A kind of promoting blood circulation and stopping pain pressure sensitive adhesive and preparation method thereof, application |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4464378A (en) * | 1981-04-28 | 1984-08-07 | University Of Kentucky Research Foundation | Method of administering narcotic antagonists and analgesics and novel dosage forms containing same |
| JPS60123417A (en) * | 1983-12-07 | 1985-07-02 | Nitto Electric Ind Co Ltd | Drug delivery member |
| US4626539A (en) * | 1984-08-10 | 1986-12-02 | E. I. Dupont De Nemours And Company | Trandermal delivery of opioids |
| US4806341A (en) * | 1985-02-25 | 1989-02-21 | Rutgers, The State University Of New Jersey | Transdermal absorption dosage unit for narcotic analgesics and antagonists and process for administration |
| DE3634016A1 (en) * | 1986-04-17 | 1987-10-29 | Lohmann Gmbh & Co Kg | AREA-BASED THERAPEUTIC SYSTEM, METHOD FOR THE PRODUCTION THEREOF AND ITS USE |
| JPS632533A (en) * | 1986-06-23 | 1988-01-07 | Yamakawa Sangyo Kk | Molded sand for precision casting |
| CH672888A5 (en) * | 1986-11-07 | 1990-01-15 | Mepha Ag | |
| EP0282156B1 (en) * | 1987-03-09 | 1991-04-17 | Alza Corporation | Composition for the prevention of contact allergy by coadministration of a corticosteroid with a sensitizing drug |
| JPH02503672A (en) * | 1987-06-01 | 1990-11-01 | ワーナー‐ランバート・コンパニー | Fatty acids and their short chain esters as penetration enhancers in aqueous systems |
| DE3843237A1 (en) * | 1988-12-22 | 1990-07-05 | Lohmann Therapie Syst Lts | TRANSDERMAL THERAPEUTIC SYSTEM WITH AN ANTIADIPOSITUM AS AN ACTIVE INGREDIENT |
-
1989
- 1989-11-29 DE DE3939376A patent/DE3939376C1/de not_active Expired - Lifetime
-
1990
- 1990-11-01 AU AU65699/90A patent/AU632182B2/en not_active Expired
- 1990-11-05 MY MYPI90001939A patent/MY105347A/en unknown
- 1990-11-05 IL IL9624390A patent/IL96243A/en not_active IP Right Cessation
- 1990-11-13 CZ CS905598A patent/CZ282557B6/en not_active IP Right Cessation
- 1990-11-13 SK SK5598-90A patent/SK279687B6/en not_active IP Right Cessation
- 1990-11-16 CA CA002030178A patent/CA2030178C/en not_active Expired - Lifetime
- 1990-11-20 ES ES90122120T patent/ES2086353T3/en not_active Expired - Lifetime
- 1990-11-20 AT AT90122120T patent/ATE135205T1/en not_active IP Right Cessation
- 1990-11-20 DE DE59010192T patent/DE59010192D1/en not_active Expired - Lifetime
- 1990-11-20 EP EP90122120A patent/EP0430019B1/en not_active Expired - Lifetime
- 1990-11-20 JP JP2312968A patent/JPH0818984B2/en not_active Expired - Lifetime
- 1990-11-20 DK DK90122120.0T patent/DK0430019T3/en active
- 1990-11-22 NZ NZ236191A patent/NZ236191A/en unknown
- 1990-11-26 NO NO905103A patent/NO303107B1/en not_active IP Right Cessation
- 1990-11-27 SI SI9012260A patent/SI9012260B/en unknown
- 1990-11-27 YU YU226090A patent/YU47956B/en unknown
- 1990-11-28 ZA ZA909544A patent/ZA909544B/en unknown
- 1990-11-28 IE IE429090A patent/IE73247B1/en not_active IP Right Cessation
- 1990-11-28 PL PL90287989A patent/PL165396B1/en unknown
- 1990-11-28 HU HU907677A patent/HU206266B/en unknown
- 1990-11-28 PT PT96028A patent/PT96028B/en not_active IP Right Cessation
- 1990-11-28 KR KR1019900019329A patent/KR950015061B1/en not_active Expired - Lifetime
- 1990-11-29 FI FI905892A patent/FI100379B/en active IP Right Grant
-
1993
- 1993-04-01 HR HRP-2260/90A patent/HRP930675B1/en not_active IP Right Cessation
-
1996
- 1996-06-06 GR GR960401538T patent/GR3020177T3/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6868286B1 (en) | 1998-11-03 | 2005-03-15 | Lts Lohmann Therapie-Systeme Ag | Device for a transdermal and phonophoretic combination therapy and the use thereof in a method for medical application |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2030178A1 (en) | Transdermal therapeutic system comprising as active component buprenorphine | |
| CA2153572A1 (en) | Transdermal therapeutic system with galanthamine as active ingredient | |
| AU6940191A (en) | Transdermal therapeutic system comprising tulobuterol as active substance | |
| CA2387143A1 (en) | Transdermal therapeutic system containing tulobuterol hydrochloride for administering the bronchodilator tulobuterol via the skin | |
| MY110391A (en) | Nitroglycerin-containing patch, a process for the production and the use thereof | |
| WO1994025025A3 (en) | Systems for controlled release of pilocarpine | |
| MY105074A (en) | Transdermal therapeutical system comprising norpseudoephedrine as active component. | |
| CA2147274A1 (en) | Transdermal therapeutic system for administering physostigmin through the skin, and method of producing the system |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |